ClinicalTrials.gg
Drug

Continuous erythropoietin receptor activator clinical trials

Also written Methoxy polyethylene glycol-epoetin beta, Mircera, R744 and RO0503821.

studies test it
71
open now
0
in phase 3
47
first study started
2001

How each study uses continuous erythropoietin receptor activator is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
14 Nov 2007 · MIRCERA · BLA 125164 (FDA, Drugs@FDA)
European Union
20 Jul 2007 · Mircera · EMEA/H/C/000739 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

methoxy polyethylene glycol-epoetin beta [Mircera]
30
C.E.R.A
2
methoxy polyethylene glycol-epoetin beta [C.E.R.A.]
2
C.E.R.A.
2
Methoxy polyethylene glycol-epoetin beta (C.E.R.A.)
2

Brand

Mircera
23

Development codes

R744
6
RO0503821
5

Other names

Methoxy polyethylene glycol-epoetin beta
27
CERA
3

Studies by the year they started

71 studies that test it; most in 2007 (21)

Studies that test continuous erythropoietin receptor activator, by start year
YearStudies
20012
20022
20047
20062
200721
200821
20096
20104
20111
20123
20131
20181

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
9
Phase 3
47
Phase 4
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 68 · Other 3

Hoffmann-La Roche (61) · Chugai Pharmaceutical (6) · Hamad Medical Corporation (1) · Taipei Veterans General Hospital, Taiwan (1) · University Hospital, Basel, Switzerland (1) · Samsung Medical Center (1)

Studies

Open first, then newest update. How each study uses continuous erythropoietin receptor activator is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 71

See all 71 studies that test continuous erythropoietin receptor activator →

Given beside what is tested · 1 — continuous erythropoietin receptor activator is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with continuous erythropoietin receptor activator

Codes

What other systems call continuous erythropoietin receptor activator · ClinicalTrials.gg INT004878

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.